A pilot multi-centre prospective randomised controlled trial of RECELL for the treatment of venous leg ulcers.


Journal

International wound journal
ISSN: 1742-481X
Titre abrégé: Int Wound J
Pays: England
ID NLM: 101230907

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 16 10 2019
accepted: 06 12 2019
pubmed: 28 2 2020
medline: 7 4 2021
entrez: 28 2 2020
Statut: ppublish

Résumé

Venous leg ulcers (VLUs) have a significant impact on approximately 3% of the adult population worldwide, with a mean NHS wound care cost of £7600 per VLU over 12 months. The standard care for VLUs is compression therapy, with a significant number of ulcers failing to heal with this treatment, especially with wound size being a risk factor for non-healing. This multicentre, prospective, randomised trial evaluated the safety and effectiveness of autologous skin cell suspension (ASCS) combined with compression therapy compared with standard compression alone (Control) for the treatment of VLUs. Incidence of complete wound closure at 14 weeks, donor site closure, pain, Health-Related Quality of Life (HRQoL), satisfaction, and safety were assessed in 52 patients. At Week 14, VLUs treated with ASCS + compression had a statistically greater decrease in ulcer area compared with the Control (8.94 cm

Identifiants

pubmed: 32103603
doi: 10.1111/iwj.13293
pmc: PMC7217204
doi:

Types de publication

Case Reports Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

742-752

Subventions

Organisme : AVITA Medical

Informations de copyright

© 2020 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Références

Burns. 2014 Mar;40(2):235-40
pubmed: 23876784
Int Wound J. 2020 Jun;17(3):742-752
pubmed: 32103603
Br Med J (Clin Res Ed). 1985 Jun 22;290(6485):1855-6
pubmed: 3924283
Br J Surg. 2015 Jan;102(2):e117-23
pubmed: 25627123
N Engl J Med. 1999 Sep 2;341(10):738-46
pubmed: 10471461
Burns. 2013 Nov;39(7):1386-90
pubmed: 23622869
Int Wound J. 2017 Apr;14(2):322-330
pubmed: 27229943
J Am Acad Dermatol. 2002 Mar;46(3):381-6
pubmed: 11862173
Wounds. 2015 Feb;27(2):31-40
pubmed: 25785905
EPMA J. 2017 Mar 3;8(1):23-33
pubmed: 28620441
J Clin Nurs. 2004 Mar;13(3):341-54
pubmed: 15009337
Plast Reconstr Surg Glob Open. 2013 Jun 07;1(2):1-3
pubmed: 25289210
J Wound Care. 2017 May 2;26(5):244-254
pubmed: 28475441
Int Wound J. 2015 Feb;12(1):32-9
pubmed: 23445302
Arch Dermatol. 1999 Aug;135(8):920-6
pubmed: 10456340
Br J Surg. 1994 Feb;81(2):182-7
pubmed: 8156328
J Adv Nurs. 2011 May;67(5):926-44
pubmed: 21241355
Cochrane Database Syst Rev. 2000;(2):CD001737
pubmed: 10796663
Ann R Coll Surg Engl. 2014 Sep;96(6):e20-2
pubmed: 25198965
Eur J Vasc Surg. 1992 May;6(3):245-51
pubmed: 1592127
Clin Dermatol. 1994 Jan-Mar;12(1):19-26
pubmed: 8180941
J Vasc Surg. 1991 Oct;14(4):557-64
pubmed: 1920653
Burns. 2007 Sep;33(6):693-700
pubmed: 17485177
Burns. 2012 Feb;38(1):44-51
pubmed: 22079538
Burns. 2007 Dec;33(8):966-72
pubmed: 17904748
N Engl J Med. 2006 Aug 3;355(5):488-98
pubmed: 16885552
Br J Surg. 1991 Jul;78(7):864-7
pubmed: 1873720
Br Med J (Clin Res Ed). 1987 Apr 11;294(6577):929-31
pubmed: 3107659
Clin Cosmet Investig Dermatol. 2011;4:7-14
pubmed: 21673869
J Wound Care. 2014 Dec;23(12):601-12
pubmed: 25492276
J Wound Care. 2013 Oct;22(10 Suppl):S11-15
pubmed: 24142135
Burns. 2012 Sep;38(6):830-9
pubmed: 22322141
J Am Acad Dermatol. 1991 Dec;25(6 Pt 1):965-87
pubmed: 1810997
BMJ Open. 2015 Dec 07;5(12):e009283
pubmed: 26644123
Br J Surg. 1986 Sep;73(9):693-6
pubmed: 3756430
J Vasc Surg. 2000 Apr;31(4):642-9
pubmed: 10753271
Wound Repair Regen. 2004 Mar-Apr;12(2):163-8
pubmed: 15086767
BMJ. 1997 Sep 6;315(7108):576-80
pubmed: 9302954
Wounds. 2007 Mar;19(3):51-63
pubmed: 26111416

Auteurs

Paul D Hayes (PD)

St John's Innovation Centre, Cambridge, UK.

Keith G Harding (KG)

Clinical Innovation Cardiff, Cardiff, Wales.

Susan M Johnson (SM)

Doncaster Royal Infirmary, Doncaster, UK.

Charles McCollum (C)

Wythenshawe Hospital, Manchester, UK.

Luc Téot (L)

Lapeyronie Health Facility, Montpellier, France.

Kevin Mercer (K)

Bradford Royal Infirmary, Bradford, UK.

David Russell (D)

Leeds General Infirmary, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH